We are live on
!
Find out more
GCM
Greywolf Capital Management Portfolio holdings
AUM
$67.3M
1-Year Est. Return
100.05%
This Fund
S&P 500
This Quarter
Est. Return
-1.06%
1 Year Est. Return
+100.05%
3 Year Est. Return
+174.41%
5 Year Est. Return
+148.91%
10 Year Est. Return
–
AUM
$565M
AUM Growth
-$334M
(-37%)
Cap. Flow
+$22.8M
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
3
Reduced
1
Closed
1
Avg Time Held Equity + Options
4.1
quarters
Top 10 Avg Time Held Equity + Options
4
quarters
Top 20 Avg Time Held Equity + Options
4.1
quarters
Avg Time Held Equity only
4.6
quarters
Top 10 Avg Time Held Equity only
4.4
quarters
Top 20 Avg Time Held Equity only
4.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$31.2M |
| 2 |
ZINC
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
|
+$11.5M |
| 3 |
MannKind Corp
MNKD
|
+$5.65M |
| 4 |
RBY
RUBICON MENERALS CORP (F)
RBY
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.2% |
| 2 | Healthcare | 20.31% |
| 3 | Industrials | 19.49% |
| 4 | Materials | 5.01% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$833B
| $253M | 44.78% |
1,230,000
-1,777,300
| -59% | -$357M |
2013 Q4
4 quarters
|
|
2
Enpro
NPO
$6.59B
| $92.5M | 16.38% |
1,473,560
| – | – |
2013 Q2
6 quarters
|
|
|
ZINC
3
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $53.8M | 9.53% |
3,400,300
+750,300
| +28% | +$11.5M |
2014 Q2
2 quarters
|
|
|
TARO
4
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $41.2M | 7.3% |
277,936
| – | – |
2013 Q2
6 quarters
|
|
|
5
MannKind Corp
MNKD
$1.06B
| $37.6M | 6.66% |
1,441,314
+200,000
| +16% | +$5.65M |
2013 Q2
6 quarters
|
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals
AMAG
| $35.9M | 6.36% |
+863,105
| New | +$31.2M |
2014 Q4
0 quarters
|
|
|
RBY
7
DELISTED
RUBICON MENERALS CORP (F)
RBY
| $28.3M | 5.01% |
29,316,542
+1,055,500
| +4% | +$1.1M |
2013 Q2
6 quarters
|
|
8
Luxfer Holdings
LXFR
$465M
| $17.5M | 3.1% |
1,173,815
| – | – |
2013 Q2
6 quarters
|
|
|
WLT
9
CALL
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
| $4.97M | 0.88% |
3,600,000
| – | – |
2014 Q3
1 quarter
|
|
|
10
American International
AIG
$40.3B
| – | – |
-493,093
| Closed | -$26.6M | – |
|
Similar funds
MUS
FVP
FTIM
RMCP
AIM
NCM
SCM
OQC
Greywolf Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Greywolf Capital Management held 10 positions worth $565M, down 37% from $899M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Greywolf Capital Management deployed $22.8M of net new capital in Q4 2014, opening 1 new position and adding to 3 existing holdings. Its largest new stake was AMAG Pharmaceuticals: 863,105 shares worth $35.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 72% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the most notable exit was American International, an estimated $26.6M sold.
- Greywolf Capital Management's largest Q4 2014 buy was AMAG Pharmaceuticals: 863,105 shares worth $35.9M.
- Greywolf Capital Management added most to HORSEHEAD HLDG CORP COM STK (DE) in Q4 2014, an estimated $11.5M increase.
- Greywolf Capital Management fully exited American International in Q4 2014, selling an estimated $26.6M.
- Greywolf Capital Management's ten largest holdings make up 100% of its $565M portfolio in Q4 2014.
- Greywolf Capital Management opened 1 new position and closed 1 in Q4 2014.
- Greywolf Capital Management's portfolio value fell 37% quarter-over-quarter to $565M.
Based on Greywolf Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.